
Comment on “breviscapine alleviates nonalcoholic steatohepatitis by inhibiting TGF-β-activated kinase 1-dependent signaling”
Author(s) -
YaRu Li,
Yuan Yao,
Liang Ma
Publication year - 2022
Publication title -
traditional medicine research
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2413-3973
DOI - 10.53388/tmr20211230256
Subject(s) - nonalcoholic steatohepatitis , steatohepatitis , medicine , transforming growth factor , cancer research , kinase , nonalcoholic fatty liver disease , microbiology and biotechnology , fatty liver , biology , disease